期刊文献+

阿司匹林用药依从性的干预研究 被引量:6

Intervention study on compliance of aspirin in clinical practice
下载PDF
导出
摘要 目的:对于使用阿司匹林预防心血管疾病的患者,通过临床药师宣传、讲解阿司匹林用药知识,了解临床药师对阿司匹林依从性的影响。方法:选择使用阿司匹林预防心血管疾病的患者262例。临床药师宣传讲解阿司匹林预防心血管疾病的疗效、用药剂量、服用时间与疗程、不良反应鉴别及减少、减轻药品不良反应的措施。宣教干预前后,给每位患者分别进行B超检查,并测定出凝血时间、血常规、肝功能、肾功能。结果:患者对阿司匹林用药预防心血管疾病的信心显著增强,患者全部相信临床药师的用药讲课。讲解干预后依从性四个检验项目(按次数服用、按剂量服药、按时服用、坚持长期用药)评分均优于干预前。胃肠道反应、出血倾向、血栓形成、肝功能异常四项指标干预后显著降低,但肾功能异常、神经系统症状及凝血障碍降低无统计意义。干预后依从性(68.3%)较干预前(23.3%)有显著提高。结论:临床药师通过讲课等形式积极干预,可以显著提高阿司匹林用药依从性。 AIM:To examine the effect of clinical pharmacists' intervention on compliance of aspirin.METHODS:262 cardiovascular patients with hypertension,diabetes,coronary heart disease,stroke or hyperlipemia were randomly chosen.Clinical pharmacists gave the patients four lessons about aspirin,such as the effect of aspirin to prevent and cure cardiovascular diseases,the canonical dosage,usage and course,the skill how to reduce adverse reactions of aspirin et.Blooding time,clotting time,routine blood test,liver function and kidney function were examined before and after the intervention.RESULTS:After four lessons about aspirin given,all the patients gained more confidence in aspirin to prevent cardiovascular disease.IPSs of the four measurement indicators of the compliance (the number,the dosage,the time,and long-term medication by doctors) were excellent than before the lessons.The occurrence rates of gastrointestinal reactions,bleeding tendency,thrombophilia,abnormal liver function were reduced significantly,the rates of abnormal kidney function,nervous system reactions and coagulopathy were reduced too.The compliance after intervention (68.3%) was higher than the compliance before intervention (23.3%) dramatically and the difference was statistically significant(P〈0.05).CONCLUSION:Clinical pharmacists can improve medication compliance of aspirin by active intervention such as give lessons.
出处 《中国临床药理学与治疗学》 CAS CSCD 2009年第10期1156-1159,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 江苏省卫生厅医学科技发展基金临床药学科研项目(200703)
关键词 阿司匹林 心血管疾病 干预 用药依从性 aspirin cardiovascular disease intervention compliance
  • 相关文献

参考文献9

二级参考文献34

  • 1曹月琴.高血压病人服药依从性研究进展[J].上海预防医学,2005,17(z1):23-24. 被引量:19
  • 2郑书成,乔宝安,陈学风.阿斯匹林新用途与不良反应[J].中国新医药,2003,2(6):69-70. 被引量:5
  • 3范维琥,谢绿洲,董乃琪,戴瑞鸿,王倩.上海市区居民高血压药物治疗概况的横断面调查[J].中国慢性病预防与控制,1994,2(5):201-202. 被引量:58
  • 4陈志明.护理干预对高血压病患者生活方式的影响[J].护理学杂志(综合版),2006,21(8):65-66. 被引量:35
  • 5Antithrombotic Trialists′ Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients.BMJ,2002,324:71-86.
  • 6Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events.The SALT Collaborative Group.Lancet,1991,338:1345-1349.
  • 7European Stroke Prevention Study 2.Efficacy and safety data.J Neurol Sci,1997,151 Suppl:S1-S77.
  • 8Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke.EAFT (European Atrial Fibrillation Trial) Study Group.Lancet,1993,342:1255-1262.
  • 9Ridker PM,Cook NR,Lee IM,et al.A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.N Engl J Med,2005,352:1293-1304.
  • 10The International Stroke Trial (IST):a randomised trial of aspirin,subcutaneous heparin,both,or neither among 19435 patients with acute ischaemic stroke.International Stroke Trial Collaborative Group.Lancet,1997,349:1569-1581.

共引文献351

同被引文献146

  • 1叶建林,张明园,姚存德,李柔水,翁正,蔡建华,候俊山,沈明华.社区中精神分裂症患者家庭的负担─—全国五城市的调查[J].临床精神医学杂志,1994,4(2):91-93. 被引量:20
  • 2高润霖,钱杰,Charles H Hennekens.预防心血管疾病:中国需要更广泛和正确地使用阿司匹林[J].中国实用内科杂志,2007,27(1):78-81. 被引量:25
  • 3张明园.精神卫生评定量表手册[M].长沙:湖南科学技术出版社,1998:154-160.
  • 4沈渔邨.精神病学[M].5版.北京:人民卫生出版社.2009:838.
  • 5Fateh-Moghadam S, Plockinger U, Cabeza N, et al, Prevalence of aspirin resistance in patients with type 2 diabetes[J]. Acta Diabetol,2005, 42(2): 99- 103.
  • 6Ertugrul DT, Tutal E, Yildiz M, et al. Aspirin re- sistance is associated with glycemic control, the dose of aspirin, and obesity in type 2 diabetes melli- tus[J]. J Clin Endocrinol Metab, 2010, 95(6): 2897-2901.
  • 7Sarwar N, Gao P, Seshasai SR, et al. Diabetes melli- tus, fasting blood glucose concentration, and risk of vascular disease: a collaborative recta-analysis of 102 prospective studies [J]. Lancet, 2010, 375 (9733) : 2215-2222.
  • 8Shah B, Sha DH, Xie DW, et al. The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume the na- tional health and nutrition examination survey, 1999-2004[J]. Diabetes Care, 2012, 35 (5): 1074- 1078.
  • 9Yngen M, Ostenson CG, Hu H, et al. Enhanced P- selectin expression and increased soluble CD40 Lig- and in patients with Type 1 diabetes mellitus and mieroangiopathy: evidence for platelet hyperactivity and chronic inflammation[J]. Diabetologia,2004, 47 (3) : 537-540.
  • 10Gresner P, Dolnik M,Waczulikova I,et al. Increased blood plasma hydrolysis of acetylsalicylic acid in type 2 diabetic patients: a role of plasma esterases [J]. Biochim Biophys Acta, 2006, 1760 (2) : 207- 215.

引证文献6

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部